0.012
price down icon2.44%   -0.0003
after-market Dopo l'orario di chiusura: .01 -0.002 -16.67%
loading

Vincerx Pharma Inc Azioni (VINC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
35.15%
7.478
5.533 10.32 11.66 15.10
Operating Income/Loss
35.15%
-7.478
-5.533 -10.32 -11.66 -15.10
Nonoperating Income/Loss
949.23%
-4.951
0.583 0.602 0.509 0.758
Income/Loss From Continuing Operations Before Tax
151.09%
-12.43
-4.95 -9.715 -11.15 -14.34
Income/Loss From Continuing Operations After Tax
151.09%
-12.43
-4.95 -9.715 -11.15 -14.34
Net Income/Loss
151.09%
-12.43
-4.95 -9.715 -11.15 -14.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
82,208%
0.0214
0.000026 0.0213 0.0213 0.0212
Diluted Average Shares
82,208%
0.0214
0.000026 0.0213 0.0213 0.0212
Basic Earnings Per Share
152.17%
-0.58
-0.23 -0.46 -0.52 -0.68
Diluted Earnings Per Share
152.17%
-0.58
-0.23 -0.46 -0.52 -0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.73
price up icon 1.44%
$31.74
price down icon 0.91%
$102.52
price up icon 2.03%
$96.25
price up icon 0.27%
biotechnology ONC
$322.90
price down icon 2.53%
$204.00
price down icon 0.51%
Capitalizzazione:     |  Volume (24 ore):